|
|
|
- CAS号:
- 58546-56-8
- 英文名:
- Schisantherin A
- 英文别名:
- Gomisin C(P);Schisantherin A;Schisantherin A-RM;SCHISANTHERINGOMISIN;Schisantherin A (Gomisin-C;Gomisin C(Schisantherin A);SCHISANTHERIN A 98.0% BY HPLC;Gomisin, 98%, from Schisandra chinensis;(5S,6S,7S,13aS)-5,6,7,8-Tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethylbenzo[3,4]cycloocta[1,2-f];Benzo[3,4]cycloocta[1,2-f][1,3]benzodioxole-5,6-diol, 5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-, 5-benzoate, (5S,6S,7S,13aS)-
- 中文名:
- 五味子酯甲
- 中文别名:
- 五味子酯甲;北五味子提取物;五味子酯甲/木脂素;五味子酯甲(标准品);五味子酯甲(对照品);五味子酯甲/HPLC;五味子酯甲(戈米辛C);五味子酯甲, 来源于五味子;北五味子提取物,五味子酯甲(标准品);五味子酯甲SCHISANTHERIN A
- CBNumber:
- CB5462083
- 分子式:
- C30H32O9
- 分子量:
- 536.57
- MOL File:
- 58546-56-8.mol
|
|
|
五味子酯甲性质、用途与生产工艺
长方形结晶 (乙醇)，mp 122℃～124℃，[α]D23 -175°(c=0.12，氯仿)。易溶于苯、氯仿、丙酮，可溶于甲醇、乙醇，难溶于石油醚，不溶于水。
五味子果仁的乙醇提取物中分离得到去氧五味子素、五味子素、五味子乙素、五味子丙素、五味子醇乙、五味子酯甲和五味子酯乙等7个有降转氨酶活性的联苯环辛烯类木脂素。七种成份都有降低SGPT、促进肝糖元生成和延长戊巴比妥睡眠时间的作用。五味子酯乙降SGPT作用最强，五味子醇乙促进肝糖元生成作用最显著，五味子丙素延长戊巴比妥睡眠时间作用最突出。
五味子为木兰科植物五味子Schisandra chinensis (Turcz.) Baill. 的干燥成熟果实。主要含有木脂素类、挥发油类、多糖类等成分。
南五味子中木脂素类成分主要有五味子酯甲、乙、丙、丁、戊和去氧五味子素。主要是五味子酯甲，含量较高。木脂素成分除五味子酯戊外，结构式在B环上都有亚甲二氧基，都可与变色酸反应。所以用五味子酯甲为对照，测得的结果基本上反映了南五味子中总木脂素的含量。
(1) 对照品溶液的配制：取五味子酯甲对照品适量，精密称定，用甲醇配制成5mg/ml的溶液即得。
(2) 样品溶液的制备：取华中五味子 (南五味子) 果实粉末约1g，精密称定。置具塞瓶中，精密加入甲醇20ml，超声处理20min，放冷至室温，摇匀，过滤，弃去初滤液，取续滤液即得。
(3) 测定：精密吸取对照品溶液20μl，供试品溶液20μl，甲醇20μl分别置具塞试管中，水浴挥去甲醇，在三个残留物中分别各精密加入10%变色酸澄清水溶液0.5ml，浓硫酸3.0ml，蒸馏水1.5ml，摇匀，同置沸水浴中加热30min，迅速冷却，以上述甲醇管为空白，照分光光度法，在570nm波长处分别测定吸收度，计算即得。
(4) 测定结果：对不同产地的南五味子药材，按所拟定的方法操作，测得其结果。
Schisantherin A (Gomisin C, Schisanwilsonin H, Arisanschinin K)是一种五味子红素，具有止咳、镇静、消炎、抗骨质疏松、神经保护、增强认知和心脏保护活性。Schisantherin A 也可通过IκBα降解抑制p65-NF-κB向核内移位。
The concentrations of TNF-α and IL-6 in the supernatant of cells pretreated with 2.5 or 25 mg/L of Schisantherin A are significantly decreased compared to the LPS control group (p<0.05, p<0.01). The potential cytotoxicity of Schisantherin A is evaluated by the MTT assay after incubating cells for 24 h in the absence or presence of LPS, result shows cell viabilities are not affected by the cytokines at concentrations used (0.5, 2.5, 25 mg/L). RAW 264.7 murine macrophage cells are pre-incubated with Schisantherin A for 1 h and then stimulated with 1 mg/L LPS for 12 h. Both LPS and samples are untreated in control group. After the cell culture media are collected, nitrite and PGE
2
levels are determined, and Schisantherin A is found to reduce NO and PGE
2
production in a dose-dependent manner.
Schisantherin A, a dibenzocyclooctadiene lignan isolated from the fruit of
Schisandra sphenanthera
, has been reported to possess varied beneficial pharmacological effects. Schisantherin A protects lipopolysaccharide-induced acute respiratory distress syndrome in mice through inhibiting NF-κB and MAPKs signaling pathways. Pretreatment with Schisantherin A markedly ameliorates LPS-induced histopathologic changes and decreases the levels of TNF-α, IL-6 and IL-1β in the BALF. In addition, the phosphorylation of NF-κB p65, IκB-α, JNK, ERK and p38 induced by LPS are suppressed by Schisantherin A. The lung wet/dry weight ratio is evaluated at 7 h after the intranasal instillation of LPS. The results show that there are no differences between control group and Schisantherin A (40 mg/kg) group (p>0.05). LPS causes a significant increase in lung wet/dry weight ratio (p<0.01) compared with the control group. Schisantherin A dose-dependently decreases the lung wet/dry weight ratio (p<0.05) compared to those in the LPS group.
五味子酯甲
上下游产品信息
上游原料
下游产品